Valeant Pharmaceuticals’ (Valeant Pharma Stock Price, Chart, News: TSX, NYSE:VRX) efforts at a... Read More
Valeant Pharmaceuticals International’s (TSX:VRX, NYSE:VRX) fourth quarter may have met with expec... Read More
Competition from generic drugmakers will affect Valeant Pharmaceuticals’ (Valeant Pharma Stock Quo... Read More
The addition of a respected board member is a positive, but Valeant Pharmaceuticals (Valeant Pharmac... Read More
The markets last week cheered Valeant Pharmaceuticals’ (TSX,NYSE:VRX) latest move to reduce it... Read More
Canaccord Genuity analyst Neil Maruoka says the sale of iNova Pharma is a solid strategic move, but ... Read More
Valeant Pharmaceuticals’ (Valeant Pharmaceutical Stock Quote, Chart, News: TSX:VRX, NYSE:VRX) ... Read More
Valeant Pharmaceuticals (Valeant Pharmaceuticals Stock Quote, Chart, News: TSX:VRX) this morning rel... Read More
Valeant Pharmaceutical’s 20-day ratio of volume traded in Call options to Put options has fallen f... Read More
The Valeant Pharmaceuticals saga promised a new chapter on Friday as short-seller Citron Research an... Read More
Valeant Pharmaceuticals (Valeant Pharmaceuticals Stock Quote, Chart, News: TSX:VRX), Canada’s larg... Read More
In refusing to overpay for Allergan, Valeant Pharmaceuticals (Valeant Pharmaceuticals Stock Quote, C... Read More
A strong third quarter from Valeant Pharmaceuticals (Valeant Pharmaceuticals Stock Quote, Chart, New... Read More
Aurion Capital Management's Greg Taylor says there are many other sizable acquisition targets for Va... Read More
The combination of Valeant Pharmaceuticals (TSX:VRX) and Allergan would be beneficial for Valeant sh... Read More
Canaccord analyst Neil Maruoka says recently completed acquisitions will drive Valeant Pharmaceutica... Read More
Valeant Pharmaceuticals (TSX:VRX) this morning announced it had changed the timing of its Q3 webcast... Read More
Valeant Pharmaceuticals (TSX:VRX) Monday paid $62.5 million to acquire the U.S. rights to Visudyne, ... Read More
Share
Tweet
pin
Share